Vivid Seats (NASDAQ:SEAT) Downgraded to Strong Sell Rating by Zacks Research

CRISPR Therapeutics’ CASGEVY Progress Reframes Growth And Valuation Story

Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?

S&P 500 and Nasdaq face a lost decade as 2000 dot-com bubble parallels turn real

HeartBeam (NASDAQ: BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development

Wall Street closes lower, posts weekly loss